Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from COSMOS Pharmaceutical Corporation ( (JP:3349) ) is now available.
COSMOS Pharmaceutical Corporation announced an increase in its year-end dividend to 37.50 yen per share for the fiscal year ended May 31, 2025, reflecting a 5 yen increase from the previous forecast. This decision aligns with the company’s policy to ensure a stable return to shareholders and follows a 2-for-1 stock split, resulting in a total annual dividend of 70 yen per share, up by 10 yen from the previous year.
The most recent analyst rating on (JP:3349) stock is a Buy with a Yen9700.00 price target. To see the full list of analyst forecasts on COSMOS Pharmaceutical Corporation stock, see the JP:3349 Stock Forecast page.
More about COSMOS Pharmaceutical Corporation
COSMOS Pharmaceutical Corporation operates in the pharmaceutical industry, focusing on providing a stable return to shareholders through a progressive dividend system while maintaining adequate internal reserves for reinvestment.
Average Trading Volume: 368,947
Technical Sentiment Signal: Buy
Current Market Cap: Yen738.1B
For a thorough assessment of 3349 stock, go to TipRanks’ Stock Analysis page.